<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Rexahn Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Rexahn Pharmaceuticals, Inc.

    Rexahn Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to developing innovative therapeutics for the treatment of cancer. Rexahn currently has two clinical stage oncology candidates, RX-3117 and RX-5902 (Supinoxin™), and additional compounds in preclinical development to treat multiple types of cancer. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Douglas J. Swirsky
    • FOUNDED
      2001
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Oneva, Inc.

    Oneva, Inc.

    Today's adults juggle caring for aging parents and children while working full-tim...

    Today's adults juggle caring for aging parents ...

    Amount Raised:    $55,053.00
    Fundraising Status:    EC
    Filing Type:    CF
    Intercept Pharmaceuticals, Inc.

    Intercept Pharmaceuticals, Inc.

    Intercept is a biopharmaceutical company focused on the development and commercial...

    Intercept is a biopharmaceutical company focuse...

    Filing Type:    PU
    Synthorx, Inc.

    Synthorx, Inc.

    Synthorx is a biotechnology company focused on prolonging and improving the lives ...

    Synthorx is a biotechnology company focused on ...

    Filing Type:    PU
    Sutro Biopharma, Inc.

    Sutro Biopharma, Inc.

    Sutro Biopharma, located in South San Francisco, is a clinical-stage drug discover...

    Sutro Biopharma, located in South San Francisco...

    Filing Type:    PU
    Teligent, Inc.

    Teligent, Inc.

    Teligent is a specialty generic pharmaceutical company (NASDAQ: TLGT). Our mission...

    Teligent is a specialty generic pharmaceutical ...

    Filing Type:    PU
    WinSanTor, Inc.

    WinSanTor, Inc.

    WinSanTor’s mission is simple-develop a drug that works. We recognize that there...

    WinSanTor’s mission is simple-develop a drug ...

    Amount Raised:    $572,649.00
    Fundraising Status:    EC
    Filing Type:    CF
    Constellation Pharmaceuticals, Inc.

    Constellation Pharmaceuticals, Inc.

    Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company using ...

    Constellation Pharmaceuticals is a clinical-sta...

    Filing Type:    PU
    Aravive, Inc.

    Aravive, Inc.

    Aravive is developing treatments designed to halt progression of life-threatening ...

    Aravive is developing treatments designed to ha...

    Filing Type:    PU
    Sierra Oncology, Inc.

    Sierra Oncology, Inc.

    Sierra Oncology is a clinical stage drug development company advancing targeted th...

    Sierra Oncology is a clinical stage drug develo...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.